Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
Rowlings, P A
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. [electronic resource] - JAMA Oct 1999 - 1335-43 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0098-7484
10.1001/jama.282.14.1335 doi
Adult
Aged
Antineoplastic Agents, Hormonal--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bone Marrow Transplantation
Breast Neoplasms--mortality
Chemotherapy, Adjuvant
Disease Progression
Female
Hematopoietic Stem Cell Transplantation
Humans
Middle Aged
Multivariate Analysis
Neoplasm Metastasis
Proportional Hazards Models
Receptors, Estrogen
Risk
Survival Analysis
Tamoxifen--therapeutic use
Transplantation, Autologous
Treatment Failure
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. [electronic resource] - JAMA Oct 1999 - 1335-43 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0098-7484
10.1001/jama.282.14.1335 doi
Adult
Aged
Antineoplastic Agents, Hormonal--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bone Marrow Transplantation
Breast Neoplasms--mortality
Chemotherapy, Adjuvant
Disease Progression
Female
Hematopoietic Stem Cell Transplantation
Humans
Middle Aged
Multivariate Analysis
Neoplasm Metastasis
Proportional Hazards Models
Receptors, Estrogen
Risk
Survival Analysis
Tamoxifen--therapeutic use
Transplantation, Autologous
Treatment Failure